Status:
COMPLETED
Observational Study of the Long-term Effect of Latanoprost in Normal Tension Glaucoma
Lead Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Conditions:
Low Tension Glaucoma
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to assess the long-term efficacy and safety of latanoprost monotherapy in patients with normal tension glaucoma (NTG) using a prospective, observational design. Visits wer...
Eligibility Criteria
Inclusion
- patients with normal-tension glaucoma
Exclusion
- none
Key Trial Info
Start Date :
August 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
902 Patients enrolled
Trial Details
Trial ID
NCT01209624
Start Date
August 1 2006
End Date
September 1 2009
Last Update
February 26 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.